Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 520-527

  Van Hal, Nicole L W ^a   Van Dongen, Guus A M S ^a   Rood Knippels, Ellen M C ^a   Van der Valk, Paul ^a   Snow, Gordon B ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HERMES ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY U36; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CLONING, MOLECULAR; EPITOPE MAPPING; HEAD AND NECK NEOPLASMS; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0029803888     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<520::AID-IJC19>3.0.CO;2-8     Document Type: Article

References (23)

1. BARKER, H.M., CRAIG, S.P., SPURR, N.K. and COHEN, P.T.W., Sequence of human protein serine/threonine phosphatase 1 gamma and localization of the gene (PPP1CC) encoding it to chromosome bands 12q24.1-q24.2. Biochim. Biophys. Acta, 1178, 228-233 (1993).
2. BRAKENHOFF, R.H., GERRETSEN, M., KNIPPELS, P.M.C., VAN DIJK, M., VAN ESSEN, H., OLDE WEGHUIS, D., SINKE, R.J., SNOW, G.B. and VAN DONGEN, G.A.M.S., The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-ancnored molecule apparently involved in keratinocyte cell-cell adhesion. J. Cell Biol., 129, 1677-1689 (1995).
3. DALL, P., HEIDER, K.H., HEKELE, A., VON MINCKWITZ, G., KAUFFMANN, M., PONTA, H. and HERRLICH, P., Surface protein expression and messenger-RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res., 54, 3337-3341 (1994).
4. DE BREE, R., ROOS, J.C., QUAK, J.J., DEN HOLLANDER, W., SNOW, G.B. and VAN DONGEN, G.A.M.S., Clinical screening of monoclonal antibodies 323/A3, cSF-25 and K928 for suitability of targeting tumors in the upper aerodigestive and respiratory tract. Nucl. Med. Commun., 15, 613-627 (1994).
5. 99m-labeled monoclonal antibody U36 in patients with head-and-neck cancer. Clin. Cancer Res., 1, 591-598 (1995).
6. FRIEDRICHS, K., KÜGLER, G., FRANKE, F., TERPE, H.J., ARLT, J., REGIDOR, P.A. and GÜNTHERT, U., CD44 isoforms in prognosis of breast cancer. Lancet, 345, 1237 (1995).
7. GEYSEN, H.M., RODDA, S.J., MASON, T.J., TRIBBICK, G. and SCHOOFS, P.O., Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods, 102, 259-274 (1987).
8. GÜNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZÖLLER, M., HAUSSMANN, I., MATZKU, S., WENZEL, A., PONTA, H. and HERRLICH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24 (1991).
9. HOFMANN, M., RUDY, W., ZÖLLER, M., TÖLG, C., PONTA, H., HER RLICH, P. and GÜNTHERT, U., CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51, 5292-5297 (1991).
10. KAUFMANN, M., HEIDER, K.H., SINN, H.P., VON MINCKWITZ, G., PONTA, H. and HERRLICH, P., CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345, 615-619 (1995).
11. KOOPMAN, G., HEIDER, K.H., HORST, E., ADOLF, G.R., VAN DEN BERG, F., PONTA, H., HERRLICH, P. and PALS, S.T., Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. exp. Med., 177, 897-904 (1993).
12. KORETZ, K., MÖLLER, P., LEHNERT, T., HINZ, U., OTTO, H.F. and HERFARTH, C., Effect of CD44v6 on survival in colorectal carcinoma. Lancet, 345, 327-328 (1995).
13. KUGELMAN, L.C., GANGLULY, S., HAGGERTY, J.G., WEISSMAN, S.M. and MILSTONE, L.M., The core protein of epican, a heparan-sulfate proteoglycan on keratinocytes, is an alternative form of CD44. J. invest. Dermatol., 99, 886-891 (1992).
14. LINDMO, T., BOVEN, E., LUTTITA, F., FEDORKO, J. and BUNN JR, P.A., Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. immunol. Methods, 72, 77-89 (1984).
15. MATSUMURA, Y., HANBURY, D., SMITH, J. and TARIN, D., Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. Brit. med. J., 308, 619-624 (1994).
16. MATSUMURA, Y. and TARIN, D., Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058 (1992).
17. MULDER, J.W., KRUYT, P.M., SEWNATH, M., OOSTING, J., SELDENRIJK, C.A., WEIDEMA, W.F., OFFERHAUS, G.J.A. and PALS, S.T., Colorectal-cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344, 1470-1472 (1994).
18. SALMI, M., GRÖN-VIRTA, K., SOINTU, P., GRENMAN, R., KALIMO, H. and JALKANEN, S., Regulated expression of exon-v6-containing iso forms of CD44 in man: down-regulation during malignant transformation of tumors of squamocellular origin. J. Cell Biol., 122, 431-442 (1993).
19. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory, New York (1989).
20. SCHRIJVERS, A.H.G.J., QUAK, J.J., UYTERLINDE, A.M., VAN WALSUM, M., MEIJER, C.J.L.M., SNOW, G.B. and VAN DONGEN, G.A.M.S., MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous-cell carcinoma of the head and neck. Cancer Res., 53, 4383-4390 (1993).
21. SCREATON, G.R., BELL, M.V., JACKSON, D.G., CORNELIS, F.B., GERTH, U. and BELL, J.I., Genomic structure of DNA encoding the lymphocytehoming receptor CD44 reveals at least 12 alternatively spliced exons. Proc. nat. Acad. Sci. (Wash.), 89, 12160-12164 (1992).
22. STUDIER, F.W., ROSENBERG, A.M., DUNN, J.J. and DUBENDORFF, J.W., Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol., 185, 60-89 (1990).
23. VAN DONGEN, G.A.M.S., BRAKENKOFF, R.H., DE BREE, R., GERRETSEN, M., QUAK, J.J. and SNOW, G.B., Progress in radioimmunotherapy of head-and-neck cancer (Review). Oncol. Rep., 1, 259-264 (1994).